Managers

Accent Therapeutics procures $40 mln Series A

Lexington, Massachusetts-based Accent Therapeutics, a biopharmaceutical company focused on treating cancer patients, has raised $40 million in Series A funding. The investors were The Column Group, Atlas Venture and EcoR1 Capital.

Five Questions with Jon Auerbach of CRV

SVB Capital raises $392 mln Sprout Endurance Partners fund

SVB Capital has raised a $392 million Sprout Endurance Partners venture capital fund, according to a filing with the SEC.

Highline BETA unveils accelerator program for women angels

Highline BETA has relaunched Female Funders Angel Academy, an accelerator program for women executives pursuing angel investing. Highline BETA's Female Funders will partner with the National Angel Capital Organization to sponsor an eight-week training program covering the fundamentals of angel investing. In the year following the training, Angel Academy members will be able to write their first investment cheque for startups sourced independently or through the Female Funders syndicate, and to co-invest with Highline BETA. Toronto-based Highline BETA is a startup co-creation and new venture development firm.

Post Venture Capital Index bounces back, gains ground in April

New Markets wraps up second fund at $68 mln

New Markets Venture Partners has closed its second fund at $68 million. The fund will focus on education technology and innovations.

Top 10: deal count and equity fall in software sector in April compared to year before

April IPO Profiles: Unicorn DocuSign leads the way

Arbor Ventures raises $178.6 mln toward second venture fund

Arbor Ventures has raised $178.6 million toward a $220 million second venture fund, according to a filing with the SEC.

Next 10 Ventures raises $50 mln

Next 10 Ventures said it has raised $50 million of financing. Its fund will focus on content creators and the firm is founded by Benjamin Grubbs, formerly global director of top creator partnerships at YouTube.